Sadek Abdelrahim A, Hassan Mohammed H, Mohammed Nesreen A
Department of Pediatrics, Pediatric Neurology and Psychiatry Unit, Faculty of Medicine, Sohag University, Sohag, Egypt.
Medical Biochemistry Department, Faculty of Medicine, South Valley University, Qena, Egypt,
Neuropsychiatr Dis Treat. 2018 Oct 5;14:2551-2561. doi: 10.2147/NDT.S176198. eCollection 2018.
Phenylketonuria (PKU) is considered to be a rare inborn error of metabolism but one of the commonest causes of mental retardation if untreated.
The present study was done to characterize the clinical patterns of PKU and analyze various neuropsychiatric outcomes in PKU children in Sohag Province, Egypt.
A prospective cohort study was conducted on 113 PKU patients, diagnosed during the period from 2012 to 2017, at the Pediatric Neurology Clinic of Sohag University Hospital, Upper Egypt. One hundred and ten cases were diagnosed based on clinical suspicion combined with laboratory confirmation by measuring their plasma phenylalanine levels using amino acid analyzer, while 3 cases were detected during neonatal screening. With the exception of the 3 cases detected during neonatal screening, all patients were clinically diagnosed and treated late. Psychometric evaluations of PKU patients were done using intelligence quotient (IQ, Stanford- Binet V), Childhood Autism Rating Scale, and Children's Attention and Adjustment Survey. Dietetic management was applied. The results of neuroimaging (computed tomography or magnetic resonance imaging of the brain) and electroencephalography were included when available.
The overall results showed that 15.9% had hyperphenylalaninemia, 35.4% had mild to moderate PKU, and classic PKU was diagnosed in 48.7%. Global developmental delay (54.9%) and delayed language (29.2%) were the most frequent presentations. Moderately impaired or delayed overall IQ was present in 77%. While, 83.2% had moderately impaired or delayed verbal IQ, autism was diagnosed in 50.4%. Super average and average probability of attention-deficit hyperactivity disorder was diagnosed in 88.5%. Abnormal neuroimaging (white matter abnormalities and brain atrophy) was the most important significant predictor for poor language and motor developmental outcome (<0.05).
PKU children had variable neuropsychological outcomes, mainly attention-deficit hyperactivity disorder and impaired verbal IQ, both of which were not related to the initial phenylalanine levels or to duration of dietary therapy, but were significantly related to early dietary intervention.
苯丙酮尿症(PKU)被认为是一种罕见的先天性代谢缺陷,但如果不治疗,是导致智力发育迟缓最常见的原因之一。
本研究旨在描述埃及索哈杰省PKU患儿的临床特征,并分析其各种神经精神方面的转归。
在埃及上埃及索哈杰大学医院儿科神经科门诊,对2012年至2017年期间诊断的113例PKU患者进行了一项前瞻性队列研究。110例患者根据临床怀疑并结合实验室确诊,使用氨基酸分析仪测量血浆苯丙氨酸水平;3例患者在新生儿筛查时被检测出。除3例新生儿筛查时被检测出的患者外,所有患者临床诊断和治疗均较晚。使用智商(IQ,斯坦福-比奈智力量表第五版)、儿童孤独症评定量表和儿童注意力与适应能力调查对PKU患者进行心理测量评估。实施饮食管理。如有神经影像学检查(脑部计算机断层扫描或磁共振成像)和脑电图检查结果也纳入分析。
总体结果显示,15.9%的患者有高苯丙氨酸血症,35.4%的患者为轻度至中度PKU,48.7%的患者被诊断为经典型PKU。全球发育迟缓(54.9%)和语言发育迟缓(29.2%)是最常见的表现。77%的患者总体智商中度受损或延迟。同时,83.2%的患者语言智商中度受损或延迟,50.4%的患者被诊断为孤独症。88.5%的患者被诊断为注意力缺陷多动障碍的可能性为超常或平均水平。异常神经影像学表现(白质异常和脑萎缩)是语言和运动发育不良转归的最重要显著预测因素(<0.05)。
PKU患儿有多种神经心理转归,主要是注意力缺陷多动障碍和语言智商受损,这两者均与初始苯丙氨酸水平或饮食治疗持续时间无关,但与早期饮食干预显著相关。